Ligand Pharmaceuticals Incorporated logo LGND - Ligand Pharmaceuticals Incorporated

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 12
HOLD 4
SELL 1
STRONG
SELL 0
| PRICE TARGET: $267.75 DETAILS
HIGH: $289.00
LOW: $252.00
MEDIAN: $265.00
CONSENSUS: $267.75
UPSIDE: 16.75%

Profitability Ratios

Ratio Value
GP Margin 97.5%
EBIT Margin 59.3%
EBITDA Margin 71.9%
Operating Margin 17.6%
Pretax Margin 59.3%
Cont. Ops Margin 46.4%
Net Margin 46.4%
Bottom Line Margin 46.4%

Liquidity Ratios

Ratio Value
Current Ratio 22.23
Quick Ratio 21.98
Solvency Ratio 0.291
Cash Ratio 4.67

Valuation Ratios

Ratio Value
Price/Earnings
29.38
Hist. avg: 34.1
Peers avg: 34.3
PEG Ratio -0.01
Forward PEG -0.01
Price/Book 3.59
Price/Sales 13.64
Price/FCF 74.76
Price/Op Cash Flow 74.07

Debt Ratios

Ratio Value
Debt/Assets 0.2893
Debt/Equity 0.4439
Debt/Capital 0.3074
Long-Term Debt/Capital 0.3049
Financial Leverage 1.53

Cash Flow Ratios

Ratio Value
Working Capital Turnover 0.49
Operating Cash Flow Ratio 1.318
Operating Cash Flow/Sales 18.4%
Free Cash Flow/Operating Cash Flow 99.1%

Coverage Ratios

Ratio Value
Debt Service Coverage 144.50
Interest Coverage 0.0000
Short-Term Operating Cash Flow Coverage 45.08
Operating Cash Flow Coverage 0.11
Capital Expenditure Coverage 109.20
Dividend + Capital Expenditure Coverage 109.20

Dividend Ratios

Ratio Value
Payout Ratio 0.0000%
Dividend Yield 0.0000%
Dividend Yield % 0.0000%
Dividend Per Share 0.0000

Per Share Ratios

Ratio Value
Revenue/Share 13.86
EPS 6.436
Debt/Share 23.3473
Cash/Share 37.93
Book Value/Share 52.60
Tangible BV/Share 25.51
Equity/Share 52.60
Operating Cash Flow/Share 2.552
Capital Expenditure/Share 0.023
FCF/Share 2.529

Other Ratios

Ratio Value
Net Income/Earnings Before Tax 0.783
Earnings Before Tax/EBIT 3.368
Price/Fair Value 3.59
Debt/Market Cap 0.1223
Effective Tax Rate 21.7%
Enterprise Value Multiple 20.41